Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
SpyGlass Pharma, Inc. (SGP) had Weighted-Average Shares Outstanding (Diluted) of 19.93B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-13.82M |
|
-- |
|
-- |
|
15.41M |
|
-15.41M |
|
1.59M |
|
-13.82M |
|
-13.82M |
|
-13.82M |
|
-13.82M |
|
-13.82M |
|
-13.82M |
|
-15.41M |
|
-15.09M |
|
19.93B |
|
|
Weighted-Average Shares Outstanding (Diluted) |
19.93B |
-0.69 |
|
-0.69 |
|
| Balance Sheet Financials | |
253.36M |
|
2.75M |
|
5.02M |
|
258.39M |
|
6.67M |
|
-- |
|
1.61M |
|
8.27M |
|
250.11M |
|
250.11M |
|
250.11M |
|
33.43M |
|
| Cash Flow Statement Financials | |
-13.54M |
|
-1.67M |
|
157.75M |
|
96.36M |
|
238.90M |
|
142.54M |
|
1.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
38.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.52% |
|
-5.52% |
|
-5.35% |
|
-5.52% |
|
7.48 |
|
-0.00 |
|
-0.00 |
|